OWA
GTBP icon

Opal Wealth Advisors’s GT Biopharma GTBP Stock Holding History

Opal Wealth Advisors’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.1K Buy
+81,811
New +$33.2K 0.01% 223

Other funds holding GTBP

EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
AIS
AM Investment Strategies Chattanooga, Tennessee $521M AUM 33.22% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
WFA
West Financial Advisors Des Moines, Iowa $659M AUM 17.93% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Opal Wealth Advisors's GTBP Position: Q2 2026 in Review

Opal Wealth Advisors opened a new position in GT Biopharma (GTBP) in Q2 2026: 81,811 shares worth $40.1K. The stake represents 0.01% of the portfolio and ranks #223 among its holdings.

12 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • Opal Wealth Advisors held 81,811 shares of GT Biopharma worth $40.1K as of Q2 2026.
  • GT Biopharma was a new Opal Wealth Advisors position in Q2 2026.
  • GT Biopharma made up 0.01% of Opal Wealth Advisors's portfolio in Q2 2026, its #223 holding.
  • 12 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.